Chemical restraints: PBAC investigates whether mirtazapine is the new risperidone
The use of mirtazapine in aged care patients was 'increasing steadily', says PBAC.
An upcoming PBAC review of antipsychotic prescribing will consider whether risperidone restrictions in aged care are behind the increasing use of other chemical restraints.
Since 2020, doctors have been barred from prescribing risperidone beyond 12 weeks without an authority script in response to the Royal Commission into Aged Care Quality and Safety’s interim report.
